Skip to content
Screener

Vor Biopharma VOR Q2 2025 earnings

Reported August 12, 2025 · Before market open

EPS-$43.60Miss by $32.20
EPS estimate-$11.40

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.81

Financials

Q2 2025

Income statement

See full
Operating income-$274.3M-845%
Net income-$1.6B-5,553%
EPS (diluted)-$12.56-2,963%

Balance sheet

See full
Cash & equivalents$190.6M+151%
Total equity-$1.5B-1,635%
Total assets$205.4M+45.0%

Cash flow

See full
Operating cash flow-$35.2M-61.0%
CapEx$152.0K+1,589%
Free cash flow-$35.3M-61.7%

FAQ

When did Vor Biopharma report Q2 2025 earnings?
Vor Biopharma (VOR) reported Q2 2025 earnings on August 12, 2025 before market open.
What were Vor Biopharma's Q2 2025 revenue and EPS?
Vor Biopharma reported eps of $-43.60 for Q2 2025.
Did Vor Biopharma beat estimates in Q2 2025?
EPS missed the consensus estimate of $-11.40 by $32.20.
How did Vor Biopharma's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 10534.1% from $-0.41.
Where can I find Vor Biopharma's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-107276) directly on SEC EDGAR. The filing index links above go to sec.gov.